These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 728896

  • 1. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
    Wara WM, Ammann AJ, Wara DW.
    Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
    [Abstract] [Full Text] [Related]

  • 2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL, McLaren JR, Skeen MJ.
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [Abstract] [Full Text] [Related]

  • 3. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
    Murray JL, Reuben JM, Smith TL, Gehan EA, Koretz SM, Hersh EM.
    J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
    [Abstract] [Full Text] [Related]

  • 4. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM, Burger DR.
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [Abstract] [Full Text] [Related]

  • 5. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR, Kukwa A, Croft CB, Borowiecki B, Silver C, Emeson EE.
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [Abstract] [Full Text] [Related]

  • 6. Improvement of impaired leukocyte migration inhibition by thymosin in patients with head and neck squamous carcinoma.
    Wolf GT, Kerney SE, Chretien PB.
    Am J Surg; 1980 Oct; 140(4):531-7. PubMed ID: 6999927
    [Abstract] [Full Text] [Related]

  • 7. [Modulation of suppressor activity by thymosin].
    Cupissol D, Thierry C, Serrou B.
    C R Seances Soc Biol Fil; 1981 Oct; 175(2):235-41. PubMed ID: 6454471
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppression and reconstitution with thymosin after radiation therapy.
    Wara WM, Wara DW, Ammann AJ, Barnard JL, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1979 Jul; 5(7):997-1001. PubMed ID: 511632
    [No Abstract] [Full Text] [Related]

  • 9. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A, Portaro J.
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [Abstract] [Full Text] [Related]

  • 10. Suppressor cell activity in cancer patients: a possible role for thymic hormones.
    Patt YZ, Hersh EM, Dicke K, Spitzer G, Mavligit GM.
    Cancer Treat Rep; 1978 Nov; 62(11):1763-8. PubMed ID: 153198
    [Abstract] [Full Text] [Related]

  • 11. Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy.
    Chretien PB, Lipson SD, Makuch R, Kenady DE, Cohen MH, Minna JD.
    Cancer Treat Rep; 1978 Nov; 62(11):1787-90. PubMed ID: 215307
    [Abstract] [Full Text] [Related]

  • 12. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W, Hölzer-Müller L, Auberger T, Clasen BP, Hohlmeier G, van Beuningen D.
    Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
    [Abstract] [Full Text] [Related]

  • 13. In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma.
    Wolf GT, Peterson KA, Lovett EJ.
    Head Neck Surg; 1985 Aug; 7(5):350-6. PubMed ID: 3879957
    [Abstract] [Full Text] [Related]

  • 14. T-cell levels and response to thymosin in vitro during intensive chemotherapy in cancer patients receiving thymosin.
    Goldberg NH, Lipson SD, Kenady DE, Simon RM, Cohen MH, Chretien PB.
    Surg Forum; 1977 Aug; 28():151-2. PubMed ID: 214880
    [No Abstract] [Full Text] [Related]

  • 15. In vitro and in viro effects of the fifth thymosin fraction.
    Litvinov VI, Averbakh MM, Novoselova VN, Gergert VY, Markov AN, Moroz AM.
    Folia Biol (Praha); 1977 Aug; 23(3):218-21. PubMed ID: 328318
    [Abstract] [Full Text] [Related]

  • 16. Immune response modulation in the spontaneously hypertensive rat.
    Strausser HR.
    Thymus; 1983 Aug; 5(1):19-33. PubMed ID: 6342214
    [Abstract] [Full Text] [Related]

  • 17. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
    Byrom NA, Campbell MA, Dean AJ, Timlin DM, Volkers C, Bodenham DC, Hobbs JR.
    Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
    [Abstract] [Full Text] [Related]

  • 18. Thymosin-dependent T-lymphocyte response in inflammatory bowel disease.
    Dopp AC, Mutchnick MG, Goldstein AL.
    Gastroenterology; 1980 Aug; 79(2):276-82. PubMed ID: 6967439
    [Abstract] [Full Text] [Related]

  • 19. Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes.
    Schmidtner J, Distel LV, Ott OJ, Nkenke E, Sprung CN, Fietkau R, Lubgan D.
    Int J Hyperthermia; 2009 Aug; 25(5):347-54. PubMed ID: 19479600
    [Abstract] [Full Text] [Related]

  • 20. Effect of thymosin treatment on antituberculous immunity in immunosuppressed mice.
    Collins FM, Auclair LK.
    J Reticuloendothel Soc; 1979 Aug; 26(2):143-53. PubMed ID: 385871
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.